{"a": [["Standards of Medical Care in Diabetes\u20142010", "2010"], ["Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)", "2003"], ["The results of direct and indirect treatment comparisons in meta\u2010analysis of randomized controlled trials", "1997"], ["Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada", "2008"], ["Prevention and management of chronic kidney disease in type 2 diabetes", "2010"], ["Effect of candesartan on prevention (DIRECT\u2010Prevent 1) and progression (DIRECT\u2010Protect 1) of retinopathy in type 1 diabetes: randomised, placebo\u2010controlled trials", "2008"], ["The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report", "2003"], ["2007 ESH\u2010ESC Practice Guidelines for the Management of Arterial Hypertension: ESH\u2010ESC Task Force on the Management of Arterial Hypertension", "2007"], ["Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals", "2001"], ["Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure", "1985"], ["Measuring inconsistency in meta\u2010analyses", "2003"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011", "2011"], ["IDF Diabetes Atlas", "2009"], ["KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease", "2007"], ["Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes", "2004"], ["Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration", "2009"], ["Prognostic significance of microalbuminuria in insulin\u2010dependent diabetes mellitus: a twenty\u2010three year follow\u2010up study", "1992"], ["Progression of nephropathy in long\u2010term diabetics with proteinuria and effect of initial anti\u2010hypertensive treatment", "1976"], ["Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes", "2009"], ["Angiotensin\u2010receptor blockers in the prevention or treatment of microalbuminuria", "2009"], ["The relationship between proteinuria and coronary risk: a systematic review and meta\u2010analysis", "2008"], ["Nephropathy in patients with type 2 diabetes mellitus", "1999"], ["The diagnosis of renal involvement in non\u2010insulin\u2010dependent diabetes mellitus", "1997"], ["Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT\u2010Protect 2): a randomised placebo\u2010controlled trial", "2008"], ["Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery", "2000"], ["Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review", "2004"], ["USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End\u2010Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009", "2009"], ["British Hypertension Society guidelines for hypertension management 2004 (BHS\u2010IV): summary", "2004"]], "ex": [["Major outcomes in high\u2010risk hypertensive patients randomized to angiotensin\u2010converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid\u2010Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)", "2002"], ["Effect of angiotensin\u2010converting\u2010enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial", "1999"], ["Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension\u20102 study", "1999"], ["Effects of intensive blood\u2010pressure lowering and low\u2010dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial", "1998"], ["Morbidity and mortality in patients randomised to double\u2010blind treatment with a long\u2010acting calcium\u2010channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)", "2000"], ["Randomised trial of effects of calcium antagonists compared with diuretics and beta\u2010blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study", "2000"], ["Effects of calcium\u2010channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators", "1999"]], "in": [["Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes", "2006"], ["Effects of a calcium channel antagonist versus an ace inhibitor on diabetic nephropathy [abstract]", "1998"], ["ADVANCE\u2010\u2010Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline", "2005"], ["Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics", "2001"], ["The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics", "2003"], ["Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design", "2003"], ["Comparison of enalapril and nifedipine in treating non\u2010insulin dependent diabetes associated with hypertension: one year analysis", "1992"], ["Hypertension and non\u2010insulin\u2010dependent diabetes", "1995"], ["Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials", "2009"], ["Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin\u2010Dependent Diabetes Mellitus", "1998"], ["Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM", "1998"], ["The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin\u2010converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators", "1996"], ["A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group", "1998"], ["The effects of losartan and fosinopril in hypertensive type 2 diabetic patients", "2002"], ["Randomized placebo\u2010controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus", "2001"], ["Beneficial effects of angiotensin\u2010converting enzyme inhibitors on cardiovascular and renal functions in patients with hypertension and diabetes", "1995"], ["Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies", "2011"], ["The effect of candesartan/placebo treatment on renal function and morphology in diabetes type 1 [abstract]", "2007"], ["Renal biopsy complications in the RASS study [abstract]", "2005"], ["Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial", "1998"], ["Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes", "2011"], ["Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients", "1997"], ["Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies", "2011"], ["Long\u2010term lisinopril therapy reduces exercise\u2010induced albuminuria in normoalbuminuric normotensive IDDM patients", "1998"], ["UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance", "1991"], ["Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients", "1996"]]}